CNS Pharmaceuticals Highlights Strategic Growth at Virtual Investor Conference
On August 27, 2026, biotechnology company CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) participated in the Virtual Investor “Why Now” on-demand conference. Led by Chief Executive Officer Rami Levin, the corporate presentation ... Read More